These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34174347)

  • 1. Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system.
    Zhang Q; He H; Cao B; Gao R; Jiang L; Zhang X; Dai J
    Neurosci Lett; 2021 Aug; 760():136084. PubMed ID: 34174347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.
    Chiappelli J; Shi Q; Kodi P; Savransky A; Kochunov P; Rowland LM; Nugent KL; Hong LE
    Psychoneuroendocrinology; 2016 Jan; 63():86-93. PubMed ID: 26431803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and evaluation of cognitive deficits in schizophrenia using "Machine learning".
    Vacca A; Longo R; Mencar C
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):261-264. PubMed ID: 31488738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
    Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
    Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.
    Kubistova A; Horacek J; Novak T
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment.
    Ribeiro-Santos R; de Campos-Carli SM; Ferretjans R; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
    Nord J Psychiatry; 2020 Apr; 74(3):187-193. PubMed ID: 31738648
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma cytokine response to surgical stress in schizophrenic patients.
    Kudoh A; Sakai T; Ishihara H; Matsuki A
    Clin Exp Immunol; 2001 Jul; 125(1):89-93. PubMed ID: 11472430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of BDNF with cytokines in chronic schizophrenia.
    Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
    Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.
    O'Brien SM; Scully P; Dinan TG
    Psychiatry Res; 2008 Sep; 160(3):256-62. PubMed ID: 18722671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Fan N; Luo Y; Xu K; Zhang M; Ke X; Huang X; Ding Y; Wang D; Ning Y; Deng X; He H
    Schizophr Res; 2015 Dec; 169(1-3):10-15. PubMed ID: 26589393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status - A case control study.
    Arabska J; Strzelecki D; Kozłowska E; Brzezińska-Błaszczyk E; Wysokiński A
    J Neuroimmunol; 2020 Oct; 347():577344. PubMed ID: 32777628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D; Prikrylova-Kucerova H; Prikryl R; Ceskova E
    Stress; 2016 Jul; 19(4):383-9. PubMed ID: 27320489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
    Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
    Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.
    Lv MH; Tan YL; Yan SX; Tian L; Chen DC; Tan SP; Wang ZR; Yang FD; Yoon JH; Zunta-Soares GB; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):165-72. PubMed ID: 24958229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
    Goldsmith DR; Haroon E; Miller AH; Strauss GP; Buckley PF; Miller BJ
    Schizophr Res; 2018 Sep; 199():281-284. PubMed ID: 29499967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia.
    Xiu MH; Wang D; Chen S; Du XD; Chen DC; Chen N; Wang YC; Yin G; Zhang Y; Tan YL; Cho RY; Soares JC; Zhang XY
    Psychiatry Res; 2018 May; 263():147-153. PubMed ID: 29554544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
    Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY
    Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.